Skip to main content

Peer Review reports

From: Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

Original Submission
4 Jun 2021 Submitted Original manuscript
3 Jul 2021 Reviewed Reviewer Report - Tuğrul Elverdi
4 Oct 2021 Reviewed Reviewer Report
24 Oct 2021 Author responded Author comments - Dorry L. Segev
Resubmission - Version 2
24 Oct 2021 Submitted Manuscript version 2
8 Nov 2021 Reviewed Reviewer Report - Tuğrul Elverdi
19 Nov 2021 Reviewed Reviewer Report
22 Nov 2021 Author responded Author comments - Dorry L. Segev
Resubmission - Version 3
22 Nov 2021 Submitted Manuscript version 3
Publishing
2 Dec 2021 Editorially accepted
27 Dec 2021 Article published 10.1186/s12885-021-09097-5

You can find further information about peer review here.

Back to article page